Avinger
Company

Last deal

$6.M

Amount

Post-IPO Equity

Stage

14.06.2024

Date

19

all rounds

$367.9M

Total amount

General

About Company
Avinger is a medical device company that develops catheter-based technologies for treating vascular diseases.

Industry

Sector :

Subsector :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's products include the Wildcat catheter for treating peripheral artery disease, the Lightbox imaging console, the Ocelot family of catheters for penetrating total arterial blockages, and Pantheris, an image-guided atherectomy device for precisely removing arterial plaque in PAD patients. Avinger's mission is to revolutionize vascular disease treatment through its lumivascular platform, the only intravascular image-guided system of therapeutic catheters in the market. The company generates the majority of its revenue from sales in the United States and was founded in 2007 by John B. Simpson, with headquarters in Redwood City, California.
Contacts